Alexander B. Olawaiye
doctorMale0.0Global Dominance: 0.00%
Dr. Alexander B. Olawaiye is the director of gynecological cancer research at Magee-Women’s Hospital at the University of Pittsburgh. He is a principal investigator in the ROSELLA trial, which explores the efficacy of the new drug Relacorilant in treating treatment-resistant ovarian cancer, showing promising results in improving overall survival rates.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Alexander B. Olawaiye, MD, director of gynecological cancer research at Magee-Women’s Hospital at the University of Pittsburgh and principal investigator in the ROSELLA trial, discussed the results with Fox News Digital.
New drug shown to fight treatment-resistant ovarian cancer, study findsFox News·
United States· 2025-04-02
United States· 2025-04-02
